Cargando…
Understanding attitudes and obstacles to vaccination against COVID-19 in patients with primary immunodeficiency
BACKGROUND: Patients with primary immunodeficiency (PID) are at increased risk for infections such as SARS-CoV-2 (COVID-19), due to the nature of their diseases and being immunocompromised. At this time, four vaccines against COVID-19 (Pfizer-BioNtech’s Comirnaty(®), Moderna’s Spikevax(®), AstraZene...
Autores principales: | Aberumand, Babak, Ayoub Goulstone, Whitney, Betschel, Stephen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9083475/ https://www.ncbi.nlm.nih.gov/pubmed/35534860 http://dx.doi.org/10.1186/s13223-022-00679-x |
Ejemplares similares
-
Monoclonal antibody treatment of COVID-19 in a pregnant woman with common variable immunodeficiency
por: Aberumand, Babak, et al.
Publicado: (2022) -
Timing of infections in patients with primary immunodeficiencies treated with intravenous immunoglobulin (IVIg)
por: Gill, Parwinder K., et al.
Publicado: (2018) -
Implications to payers of switch from hospital-based intravenous immunoglobulin (IVIg) to home-based subcutaneous immunoglobulin (SCIg) therapy in patients with primary immunodeficiencies (PID) and secondary immunodeficiencies (SID) in Canada
por: Gerth, William C, et al.
Publicado: (2014) -
Implications to payers of switch from hospital-based intravenous immunoglobulin to home-based subcutaneous immunoglobulin therapy in patients with primary and secondary immunodeficiencies in Canada
por: Gerth, William C, et al.
Publicado: (2014) -
Monitoring patients with uncomplicated common variable immunodeficiency: a systematic review
por: Lee, Erika Yue, et al.
Publicado: (2022)